mRNA Synthesis & Manufacturing Market to Hit USD 2958.3 million by 2029 with 5.8% CAGR | MarketsandMarkets™
29. Oktober 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Delray Beach, FL, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The global mRNA synthesis and manufacturing market is projected to grow from USD 2,231.4 million in 2024 to USD 2,958.3 million by 2029, at a CAGR...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
28. September 2023 15:48 ET
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio to Present at Jefferies Healthcare Conference 2023
08. Juni 2023 09:05 ET
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
The mRNA synthesis and mRNA manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis
26. Januar 2023 11:25 ET
|
Roots Analysis
London, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Synthesis and mRNA Manufacturing Services Market (2nd Edition), 2022–2035” report to its list of...
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
12. Oktober 2022 09:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands
26. September 2022 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, will showcase its recently released BioXp™ 9600 system at the...
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
19. September 2022 07:00 ET
|
Codex DNA, Inc.
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the...
Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits
22. November 2021 08:03 ET
|
Codex
San Diego, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, and RNAimmune, a leading biotech company with expertise in...